Zinc is involved in sebum regulation, immune function, and tissue repair. It has been tested against antibiotics for acne. The results are more nuanced than the supplement industry suggests.
Zinc deficiency affects an estimated one-third of the global population, making it one of the most common micronutrient deficiencies worldwide. In the skin, zinc plays roles in sebum regulation, wound healing, immune function, and the inhibition of bacterial growth. It has been tested in controlled trials for acne, wound healing, and hair loss. The evidence is real but requires careful interpretation — particularly the distinction between correcting a deficiency and supplementing in a zinc-replete individual.
Acne vulgaris involves four interacting factors: excess sebum production, follicular hyperkeratinisation, colonisation by Cutibacterium acnes (formerly Propionibacterium acnes), and the resulting inflammatory response. Zinc addresses at least three of these. It inhibits 5-alpha reductase (reducing androgen-driven sebum production), has direct antibacterial activity against C. acnes, and suppresses the production of pro-inflammatory cytokines (TNF-α, IL-6) through its role as a cofactor for anti-inflammatory enzymes.
The most clinically useful evidence comes from trials comparing oral zinc to oral antibiotics. A 2021 open-label study by Tolino et al. compared 400 mg/day zinc sulphate to lymecycline (a tetracycline antibiotic) in patients with mild to moderate papulopustular acne over 12 weeks. Zinc sulphate produced similar reductions in the Global Acne Grading System (GAGS) score to lymecycline. Crucially, zinc produced significantly higher improvements in quality-of-life scores (AQoL) than lymecycline — a finding that deserves attention given the increasing concern about antibiotic resistance in acne management.
A 2005 study by Dreno et al. (n=30) found that 30 mg/day zinc gluconate for two months reduced inflammatory lesions and — importantly — reduced the in vitro resistance of C. acnes strains to erythromycin. This suggests that zinc may have a role in preserving antibiotic efficacy, not just as a standalone treatment.
Oral zinc sulphate (400 mg/day) showed similar efficacy to lymecycline in reducing acne severity, with significantly higher improvement in quality-of-life scores. Zinc does not cause antibiotic resistance.
— Tolino E et al., J Clin Aesthet Dermatol, 2021
Zinc is less effective than oral antibiotics in most head-to-head trials for moderate to severe acne. The Tolino comparison was in mild to moderate disease. For severe acne, isotretinoin and antibiotics remain the standard of care. Zinc is a reasonable first-line option for mild acne, particularly in patients who want to avoid antibiotics, but it is not a substitute for dermatological evaluation in moderate or severe disease.
The dose matters. The trials that show efficacy use 30–400 mg/day of elemental zinc (as gluconate or sulphate). Standard dietary supplement doses (10–15 mg/day) are unlikely to produce the same effects. At high doses, zinc can cause nausea, copper depletion (zinc and copper compete for absorption), and — paradoxically — hair loss. Supplementation above 40 mg/day of elemental zinc should be monitored.
Zinc is an essential cofactor for over 300 enzymes, including those involved in collagen synthesis, cell proliferation, and immune function — all critical for wound healing. Zinc deficiency impairs wound healing; zinc supplementation in deficient individuals accelerates it. In zinc-replete individuals, the evidence for supplementation improving wound healing is weaker. Topical zinc oxide has the strongest evidence for wound healing applications and is a standard ingredient in wound dressings.
Vitaei verdict
Zinc has genuine evidence for mild to moderate acne at therapeutic doses (30–400 mg/day elemental zinc). It is a reasonable antibiotic-sparing option. For wound healing and hair loss, it is most useful in correcting deficiency rather than supplementing above normal levels. Test serum zinc before supplementing at high doses — both deficiency and excess are problematic.
Skin ageing at the cellular level: the 12 hallmarks applied to skin
The same nine — now twelve — hallmarks that drive systemic ageing play out in skin with unusual visibility. Understanding them explains why some interventions work and most don't.
Nicotinamide for skin: the overlooked B3 vitamin with dermatology-grade evidence
While the longevity world focuses on NMN and NR, nicotinamide — the simplest form of vitamin B3 — has a Phase 3 RCT showing 23% reduction in skin cancers. That evidence deserves more attention.
The collagen synthesis pathway: why vitamin C is non-negotiable
Collagen is the most abundant protein in the human body. Vitamin C is required to make it. This is not a supplement claim — it is biochemistry. Here is the pathway, and what happens when it fails.